Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Botox for Chronic Pelvic Pain

NCT: NCT06796985 · RECRUITING

NCT IDNCT06796985
StatusRECRUITING
Start Date2025-02-24
Completion2027-03-22
SponsorUniversity of Miami (OTHER)
First posted
Last updated

Brief Summary

The purpose of this research study is to find out if precise, targeted injection of botulinum neurotoxin (commonly known as Botox) provides better relief of pelvic floor hypertonicity and pain than the standard method being used. The researchers want to better understand the effects (good and bad) of targeted botulinum neurotoxin injections in women with pelvic floor disorders.

Frequently Asked Questions

What is Botox for Chronic Pelvic Pain?

Botox for Chronic Pelvic Pain is a clinical trial registered under NCT06796985. Current status: RECRUITING.

What is the status of NCT06796985?

The current status of NCT06796985 (Botox for Chronic Pelvic Pain) is: RECRUITING.

When did Botox for Chronic Pelvic Pain start?

Botox for Chronic Pelvic Pain started on 2025-02-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.